Related Experiment Videos
Thromboembolism in cancer. Changing trends
J E Naschitz1, D Yeshurun, L M Lev
1Department of Internal Medicine A, Bnai Zion Medical Center, Haifa, Israel.
Cancer
|February 15, 1993
Summary
Paraneoplastic thromboembolism (TE) presents complex challenges. Unexplained TE may indicate hidden cancer, but targeted clues can guide diagnosis and treatment, improving outcomes.
Area of Science:
- Oncology
- Hematology
- Thrombosis
Background:
- Paraneoplastic thromboembolism (TE) is a complex clinical challenge.
- Unexplained TE can be an early indicator of an occult malignancy.
- Identifying specific clues is crucial for diagnosing TE associated with hidden cancers.
Purpose of the Study:
- To review classic and new manifestations of paraneoplastic TE.
- To discuss the role of cancer cells in TE pathogenesis.
- To evaluate novel treatment approaches for paraneoplastic TE.
Main Methods:
- Review of existing literature on paraneoplastic TE.
- Analysis of hemostatic alterations in cancer patients.
- Discussion of diagnostic clues for occult malignancy in TE patients.
Main Results:
- Cancer cells contribute to TE through endothelial injury, platelet activation, and coagulation dysregulation.
- Standard anticoagulant therapy may be insufficient in many paraneoplastic TE cases.
- Novel treatments like low-molecular-weight heparin or Greenfield filters show promise.
Conclusions:
- Paraneoplastic TE requires careful consideration due to its complexity.
- Specific clues can aid in detecting underlying malignancies.
- Advanced treatments may offer better outcomes than standard anticoagulation.